No ASX ETF holds Starpharma (SPL) as of 15 Oct 2026. Over the last year it rose 163.2%: on $10,000, +$16316. We explain 20 big moves in that time.
About SPL
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$398.2m
- Held by0 ETFs
- Big moves20 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −8.6%peak −10.3%1 Oct 2026· Management
A board chair and deputy chair appointment announcement appears to have unsettled investors, driving an outsized sell-off beyond what sector weakness alone can explain.
- +4.3%peak +5.8%13 Aug 2026· Stake Change
Multiple directors purchased shares through the recently completed $32 million entitlement offer, signalling strong insider confidence and prompting a positive market re-rating of the stock.
- −5.4%12 Aug 2026· Capital Raise
Starpharma launched a $32 million capital raise, causing dilution and a sharp drop in the stock price.
- −7.5%peak −19.9%11 Aug 2026· Capital Raise
Starpharma's stock fell sharply after completing a $32 million renounceable entitlement offer, with new shares being quoted, causing dilution-driven selling pressure.
- +6.7%peak +8.0%5 Aug 2026· Unknown
SPL.AX rose sharply alongside a broader lift in the ASX healthcare sector, likely driven by a general sector rotation or positive sentiment across health stocks rather than any company-specific news.
- +8.0%28 Jul 2026· Sector Flow
SPL.AX rose strongly alongside a broad rally in Australian healthcare sector stocks, lifting the stock on sector-wide buying momentum.
- +8.2%19 May 2026· Sector Flow
No clear single cause identified; move appears tied to general ASX growth/sector interest around the date.
- −11.3%19 May 2026· Unknown
No direct news explains the 11.29% drop; likely reflects market sentiment from a generic analyst/sector commentary, but evidence is insufficient.
- −10.2%15 May 2026· Unknown
No specific event identified; the price decline appears to be a continuation of negative sentiment from a previous day's fall, likely tied to a general market or sector move.
- −6.0%29 Apr 2026· Unknown
No direct company-specific news explains the drop; likely broad sector or market flow given the generic nature of surrounding articles.
- +9.8%16 Apr 2026· Sector Flow
No specific company announcement found; the stock's rally appears to be part of a broader uptrend and technical breakout, as highlighted by multiple market analysis articles.
- +15.0%15 Apr 2026· Sector Flow
A significant bullish move in Starpharma's stock on April 15, 2026, without direct news coverage, likely due to a sector-wide rally in ASX 200 healthcare stocks.
- +13.4%16 Mar 2026· Unknown
Insufficient news evidence to explain the abnormal price move.
- −7.5%4 Mar 2026· Unknown
No relevant news explains the price drop; likely due to broader market or unidentified factors.
- +18.1%11 Feb 2026· Stake Change
A substantial shareholding change announcement on the event date likely triggered investor interest, possibly indicating insider or activist accumulation.
- +13.5%3 Feb 2026· Unknown
Insufficient evidence to attribute the price move to a specific driver.
- +16.2%29 Jan 2026· Sector Flow
No direct news explains the move; likely driven by sector-wide gold exploration excitement following peer drilling results.
- +15.6%12 Nov 2025· Unknown
No specific cause identified; available news articles are unrelated to Starpharma Holdings.
- +13.2%11 Nov 2025· Unknown
Insufficient direct evidence; the price move may be influenced by sector news such as Nimy Resources' gallium resource update, but no direct link to Starpharma found.
- +9.0%29 Oct 2025· Unknown
Insufficient news evidence to determine the cause of the price move.
Held by 0 ETFs
No ETF we track holds SPL directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did SPL rise 13.5% on 3 Feb 2026?
Starpharma
Insufficient evidence to attribute the price move to a specific driver.
The provided news articles are generic market summaries and do not mention STARPHARMA HOLDINGS LIMITED or any specific event related to the company around the event date. The large price move and volume spike cannot be linked to any news, so the cause remains unknown.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage